Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2019-07, Vol.16 (7), p.e1002842
Hauptverfasser:	Dooley, Kelly E, Hanna, Debra, Mave, Vidya, Eisenach, Kathleen, Savic, Radojka M
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antiretroviral agents Antitubercular agents Antitubercular Agents - adverse effects Antitubercular Agents - pharmacokinetics Antitubercular Agents - therapeutic use Bedaquiline Biology and Life Sciences Biomarkers Clinical pharmacology Clinical trials Collection Review Combination drug therapy Computer simulation Decision making Diagnostic microbiology Drug Development Drug dosages Drug interaction Drug interactions Drug resistance Drugs HIV Human immunodeficiency virus Humans Immune system Immunosuppressive agents Infections Medicine Medicine and Health Sciences Metabolism Microbial Sensitivity Tests Microbiology Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - pathogenicity Parameter estimation Parameter uncertainty Patients Pharmacology Pharmacology, Clinical Population studies Product development Research and analysis methods Rifapentine Translation Translational Medical Research Translational research Tuberculosis Tuberculosis - diagnosis Tuberculosis - drug therapy Tuberculosis - microbiology Womens health Workflow
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!